An2 Therapeutics, Inc. · NASDAQ:ANTX
TCG Crossover GP I, LLC's stake in An2 Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
TCG Crossover GP I, LLC's stake in An2 Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP I, LLC | 0% | 0 |
| TCG Crossover Fund I, L.P. | 0% | 0 |
| Chen Yu | 0% | 0 |